Benjamin J. Zeskind
PRESIDENT AND CEO at Immuneering Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Immuneering Corporation, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immuneering Corporation June 12, 2024100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Immuneering Corporation | Open-market purchase | +2,400 | $4.56 | $10,944 |
| Jul 2, 2025 | Immuneering Corporation | Open-market purchase | +7,015 | $3.53 | $24,763 |
| Jul 1, 2025 | Immuneering Corporation | Open-market purchase | +2,985 | $3.38 | $10,089 |
| Jun 18, 2025 | Immuneering Corporation | Open-market purchase | +21,000 | $2.39 | $50,190 |
| Mar 19, 2024 | Immuneering Corporation | Open-market purchase | +20,000 | $2.77 | $55,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.